Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

From- Fondazione Per La Ricerca Ospedale Di Bergamo- Ets

Clinical trials sponsored by From- Fondazione Per La Ricerca Ospedale Di Bergamo- Ets, explained in plain language.

Trials to join now! 6 Not yet finished but already full! 1 Completed 3

Tracking a new blood cancer drug in everyday practice

Disease control Ongoing

This study is observing how well patients with polycythemia vera (a rare blood cancer) tolerate and respond to the drug ropeginterferon alfa-2b in real-world clinics, not a controlled trial. It aims to see how often the drug is prescribed, how many patients can stay on it, and it…

Sponsor: FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS • Aim: Disease control

Last updated Mar 09, 2026 14:23 UTC